[144] Addus HomeCare Corp. SEC Filing

Rhea-AI Filing Summary

Addus HomeCare Corp. (ADUS) Form 144 shows a proposed sale of 4,000 common shares through Morgan Stanley Smith Barney on 09/02/2025 on NASDAQ, with an aggregate market value of $462,982.40 and 18,407,239 shares outstanding. The filing details that the shares were received as restricted stock in four grants between 03/02/2019 and 03/02/2022 totaling 4,000 shares. It also discloses a prior sale by the same person of 9,000 common shares on 08/13/2025 for gross proceeds of $1,038,105.91. The filer certifies no undisclosed material adverse information.

Positive

• Disclosure compliance: Filing provides required Rule 144 details including broker, acquisition dates, and share counts
• Transparency on prior sales: Reports a recent 9,000-share sale with gross proceeds of $1,038,105.91

Negative

• Insider selling: Proposed sale of 4,000 shares and a recent 9,000-share sale indicate insider liquidity events which may concern some investors

Insights

Securities Analyst

TL;DR: Insider plans to sell restricted shares totaling 4,000 shares; a recent 9,000-share sale was also reported.

The Form 144 identifies a proposed open-market sale of 4,000 common shares by an insider through Morgan Stanley Smith Barney with an indicated aggregate market value of $462,982.40 and an approximate sale date of 09/02/2025. The filing states the shares originated from employer restricted stock grants between 2019 and 2022. The record of a 9,000-share sale on 08/13/2025 for $1,038,105.91 is also disclosed. From a trading-activity perspective, these disclosures document insider liquidity events but do not provide company operational or financial details.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 notice requirements; confirms insider certification about material information.

The notice contains required transaction details: class, broker, amount, acquisition dates and nature (restricted stock), and a certification that the seller is unaware of undisclosed material adverse information. The presence of multiple recent sales is notable for governance monitoring but the filing contains no indications of violations or unusual transfer mechanisms. It is a routine regulatory disclosure of insider disposals rather than a corporate-action filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4000	462982.40	18407239	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2020	Restricted Stock	Issuer			387	03/01/2020	Not Applicable
Common	03/02/2022	Restricted Stock	Issuer			1609	03/02/2022	Not Applicable
Common	02/24/2022	Restricted Stock	Issuer			1182	02/24/2022	Not Applicable
Common	03/02/2019	Restricted Stock	Issuer			822	03/02/2019	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
BRAD BICKHAM 6303 Cowboys Way, Suite 600 Frisco TX 75034	Common	08/13/2025	9000	1038105.91

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ADUS Form 144 disclose about the proposed sale?

It discloses a proposed sale of 4,000 common shares through Morgan Stanley Smith Barney on 09/02/2025 with an aggregate market value of $462,982.40.

How were the shares to be sold for ADUS acquired?

The shares were acquired as restricted stock in grants dated 03/02/2019, 03/01/2020, 02/24/2022, and 03/02/2022 totaling 4,000 shares.

Did the filer recently sell ADUS shares?

Yes. The filing reports a prior sale by the same person of 9,000 common shares on 08/13/2025 for gross proceeds of $1,038,105.91.

Through which broker will the proposed ADUS sale be executed?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ.

Does the Form 144 assert anything about undisclosed material information?

Yes. The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.